Target intelligence / Profile preview

SNAP receptor protein (SNARE)

Target
SNARE
Molecular classification
Other (membrane fusion machinery protein family), Receptor (historically: SNAP receptor, but mechanistically not a classical cell-surface receptor), Protein complex component
01

Overview

The SNAP receptor protein family, commonly abbreviated as SNARE proteins, are a large family of membrane-associated proteins that mediate the fusion of vesicles with their target membranes, a process essential for neurotransmitter release, hormone secretion, and general cellular membrane trafficking[1][3][4]. The term “SNAP receptor” (“SNARE”) specifically refers to proteins that interact with soluble NSF attachment proteins (SNAPs) and are disassembled by the N-ethylmaleimide-sensitive factor (NSF) post-fusion. The canonical SNARE complex is composed of v-SNAREs (found on vesicles, e.g., synaptobrevin/VAMP) and t-SNAREs (on target membranes, e.g., syntaxin, SNAP-25), forming a four-helix bundle that brings membranes together to facilitate fusion[1][3][4][5]. SNAREs are not classical receptor proteins but are so named for their historical identification as SNAP “receptors” because they bind SNAPs in experimental models[1][3]. While essential for basic cellular processes and targeted by toxins such as botulinum toxin, the SNARE protein family is not, as a whole, considered a classical therapeutic target. Instead, specific SNARE family members (such as SNAP-25 or synaptobrevin) may be considered putative targets in certain contexts, but “SNAP receptor protein family” as a whole is too broad and mechanistically ill-defined for standard drug targeting[6]. The family plays absolutely central roles in membrane trafficking but does not present as a direct, specific drug receptor in the conventional sense, and the query as written is ambiguous and possibly incorrect in scope and terminology[1][3].

Other names
Soluble NSF attachment protein receptorSNARE protein familySNAP receptors
02

Biological functions

Membrane fusionVesicular transportNeurotransmitter releaseExocytosisEndocytosis
03

Disease associations

Neurodegenerative diseaseOther (as general vesicle fusion machinery, dysfunction may contribute to various cellular pathologies)
04

Safety considerations

Fundamental to vesicle trafficking; global perturbation would impair cell viabilityNo established druggability or specific targeting without systemic toxicity.

Beyond the preview

Go deeper on SNAP receptor protein (SNARE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNAP receptor protein (SNARE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call